Shanghai INT Medical Instruments Co., Ltd. - Laporan Laba Rugi (TTM)

Shanghai INT Medical Instruments Co., Ltd.
HK ˙ SEHK ˙ CNE100003NH7
HK$ 32.66 ↓ -0.82 (-2.45%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Shanghai INT Medical Instruments Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 341 358 363 367 416 465 487 509 548 586 643 700 727 753 779 805 829 852 886 921
Change (%) 5.16 1.22 1.21 13.27 11.72 4.80 4.58 7.52 6.99 9.78 8.91 3.74 3.61 3.49 3.37 2.89 2.81 4.04 3.88
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 121 124 127 131 160 189 207 225 239 253 273 292 303 315 318 321 318 314 337 359
Change (%) 2.51 2.68 2.61 22.29 18.23 9.66 8.81 6.20 5.84 7.54 7.01 3.97 3.82 0.98 0.97 -1.03 -1.04 7.14 6.66
% of Revenue 35.49 34.60 35.10 35.59 38.42 40.66 42.55 44.27 43.72 43.25 42.37 41.63 41.73 41.81 40.79 39.84 38.33 36.89 37.99 39.01
Gross Operating Profit 220 234 235 237 256 276 280 284 308 332 371 409 423 438 461 484 511 538 550 562
Change (%) 6.62 0.45 0.45 8.29 7.66 1.47 1.45 8.57 7.89 11.48 10.30 3.58 3.45 5.30 5.03 5.49 5.20 2.22 2.17
% of Revenue 64.51 65.40 64.90 64.41 61.58 59.34 57.45 55.73 56.28 56.75 57.63 58.37 58.27 58.19 59.21 60.16 61.67 63.11 62.01 60.99
SG&A 63 57 59 60 70 80 88 96 109 122 131 140 154 167 177 186 193 200 209 218
Change (%) -8.82 2.01 1.97 16.64 14.27 10.42 9.44 13.18 11.64 7.47 6.95 9.82 8.94 5.75 5.44 3.52 3.40 4.64 4.43
% of Revenue 18.48 16.03 16.15 16.27 16.76 17.14 18.06 18.90 19.89 20.76 20.32 19.96 21.13 22.21 22.70 23.15 23.30 23.43 23.56 23.69
R&D 56 65 72 79 85 90 86 83 91 100 113 126 126 126 129 132 141 149 149 149
Change (%) 14.40 11.49 10.30 6.62 6.21 -3.96 -4.13 10.15 9.21 13.38 11.80 -0.18 -0.18 2.45 2.39 6.49 6.09 -0.17 -0.17
% of Revenue 16.57 18.02 19.85 21.63 20.36 19.36 17.74 16.26 16.66 17.01 17.56 18.03 17.35 16.72 16.55 16.39 16.96 17.50 16.80 16.14
OpEx 226 233 240 247 283 320 351 382 419 457 496 535 563 591 604 619 630 640 667 695
Change (%) 3.07 2.95 2.87 14.83 12.91 9.73 8.87 9.70 8.85 8.59 7.91 5.23 4.97 2.18 2.48 1.88 1.52 4.29 4.11
% of Revenue 66.35 65.03 66.14 67.22 68.14 68.87 72.12 75.07 76.60 77.92 77.08 76.37 77.47 78.48 77.49 76.82 76.07 75.11 75.30 75.47
Operating Income 115 125 123 120 132 145 136 127 128 129 147 165 164 162 175 187 198 212 219 226
Change (%) 9.29 -1.99 -2.03 10.09 9.16 -6.12 -6.51 0.94 0.93 13.98 12.26 -1.06 -1.07 8.27 6.45 6.23 6.91 3.26 3.16
% of Revenue 33.65 34.97 33.86 32.78 31.86 31.13 27.88 24.93 23.40 22.08 22.92 23.63 22.53 21.52 22.51 23.18 23.93 24.89 24.70 24.53
Interest Expense -0 -0 -0 -0 -0 -1 -1 -1 -1 -1 -1 -2 -2 -3 -3 -3 -3 -2 -3 -4
Change (%) -62.75 145.11 59.20 38.16 27.62 0.55 0.55 13.91 12.21 53.97 35.05 43.89 30.50 -2.71 -2.78 -9.78 -10.84 38.74 27.93
% of Revenue -0.07 -0.03 -0.06 -0.10 -0.12 -0.14 -0.13 -0.13 -0.13 -0.14 -0.20 -0.24 -0.34 -0.42 -0.40 -0.38 -0.33 -0.29 -0.38 -0.47
Net Income 121 121 113 105 124 143 143 143 137 132 147 161 159 156 166 176 184 192 191 190
Change (%) 0.67 -6.92 -7.43 18.36 15.51 0.08 0.08 -4.01 -4.18 11.26 10.12 -1.52 -1.55 6.40 6.02 4.37 4.19 -0.52 -0.53
% of Revenue 35.37 33.86 31.13 28.48 29.76 30.77 29.38 28.12 25.10 22.48 22.79 23.04 21.87 20.78 21.37 21.91 22.23 22.53 21.54 20.63

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista